For a peptide like tirzepatide, freezing is also not recommended but some formulations tolerate it briefly
What I would like to see next If BPC-157 truly helps acute soft tissue injury, it should be demonstrable in well-designed human studies with practical endpoints: time to return to sport, functional scores, re-injury rates, adverse events, and standardized imaging where appropriate
Our GHK-Cu is verified at 99%+ purity by high-performance liquid chromatography (HPLC)
What the 28-day window requires: The clock starts at first puncture, not at the date printed on the vial
While clinics may market these compounds aggressively, their benefits remain unproven and their safety uncertain
Research Background In preclinical (animal and in vitro) models, BPC-157 has been studied as a cytoprotective peptide of interest in gastrointestinal, musculoskeletal, and vascular research